Concerns for Development After Bevacizumab Treatment of ROP-Reference-Cited by-同舟云学术

Concerns for Development After Bevacizumab Treatment of ROP

Published:2016-04-01 Issue:4 Volume:137 Page:
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Quinn Graham E.¹,Darlow Brian A.²

Affiliation:

1. Division of Ophthalmology, The Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; and

2. Department of Paediatrics, University of Otago, Christchurch, New Zealand

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2016-0057/1095650/peds_20160057.pdf

Reference27 articles.

1. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.;Early Treatment for Retinopathy of Prematurity Cooperative Group;Arch Ophthalmol,2003

2. Final visual acuity results in the early treatment for retinopathy of prematurity study.;Good;Arch Ophthalmol,2010

3. Incidence and early course of retinopathy of prematurity.;Palmer;Ophthalmology,1991

4. 15-Year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.;Palmer;Arch Ophthalmol,2005

5. Risk analysis of prethreshold retinopathy of prematurity.;Hardy;Arch Ophthalmol,2003

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinopathy of prematurity (ROP): From the perspective of the neonatologist;Global Pediatrics;2024-06

2. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial;eClinicalMedicine;2024-05

3. RPE und der vaskuläre endotheliale Wachstumsfaktor (VEGF);Das Retinale Pigmentepithel – Physiologie und Pathologie;2024

4. Eye and Vision Disorders;Avery's Diseases of the Newborn;2024

5. Effects of fresh bone marrow mononuclear cell therapy in rat model of retinopathy of prematurity;Regenerative Therapy;2023-12